References

[al-Saadi2002] al-Saadi N, Gross M, Paetsch I, Schnackenburg B, Bornstedt A, Fleck E, Nagel E. Dobutamine induced myocardial perfusion reserve index with cardiovascular MR in patients with coronary artery disease. J Cardiovasc Magn Reson. 2002; 4(4):471-480.

[ESC2013]  Montalescot G et al., 2013 ESC guidelines on the management
of stable coronary artery disease. The Task Force on the management of stable coronary artery disease
of the European Society of Cardiology. European Heart Journal. 2013; 34:2949-3003

[FAMEII] De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA et al., FAME 2 Trial Investigators. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012 Sep 13;367(11):991-1001.

[Hachamovitch2011] Hachamovitch R, Rozanski A, Shaw LJ, Stone GW, et al. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. Eur Heart J 2011; 32: 1012-1024

[Lubbers2008] Lubbers DD, Janssen CHC, Kuijpers D, van Dijkman PRM, Overbosch J, Willems TP, Oudkerk M. The additional value of first pass myocardial perfusion imaging during peak dose of dobutamine stress cardiac MRI for the detection of myocardial ischemia. Int J Cardiovasc Imaging. 2008; 24:69-76.

[Manka2011] Manka R, Jahnke C, Gebker R, Schnackenburg B, Paetsch I. Head-to-head comparison of first-pass MR perfusion imaging during adenosine and high-dose dobutamine/atropine stress. Int J Cardiovasc Imaging. 2011; 27:995-1002.

[Patel2012] Patel MR, Bailey SR, Bonow RO, Chambers CE, Chan PS, Dehmer GJ, Kirtane AJ, Wann LS, Ward RP. ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 Appropriate Use Criteria for Diagnostic Catheterization. J Am Coll Cardiol 2012; 59: 1995-2027.

[Schinkel2003] Schinkel AFL et al. Noninvasive evaluation of ischaemic heart disease: myocardial perfusion imaging or stress echocardiography? Eur Heart J 2003; 24:789-800.

[Shaw2008] Shaw LJ, Berman DS, Maron DJ, et al. Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy. Circulation. 2008;117:1283-1291

[Venkatesh2011]Venkatesh LM, Masanao N, Courtney RF et al. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation. 2011;124:2215-2224.